# PCI Pharma Services announces $20M expansion for biotech packaging

PCI Pharma Services invested over $20 million to expand biotech clinical and commercial packaging and release testing capability at its Center of Excellence in Philadelphia, and expand cold chain capacity at global locations.

- Type: Investment
- Announced: 2019-01-07
- Where: Philadelphia, Pennsylvania, United States
- Value: $20.0M
- Status: announced
- Products: biologic medicines, injectable delivery forms, safety syringes, autoinjectors, pen devices
- Sectors: [Packaging](https://endata.com/sectors/packaging.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [PCI Pharma Services](https://endata.com/companies/3896.md)

## Sources

- [drug-dev.com](https://drug-dev.com/pci-pharma-services-announces-20-million-expansion-of-biotech-technologies-including-advanced-injectable-delivery-forms/), 2019-01-07: "It’s estimated that close to 40 per cent of all medicines in pipeline development are biologic, and amazing new therapies are being developed and commercialized every day."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.